Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer (original) (raw)

• Akiyama Y, Maesawa C, Ogasawara S, Terashima M, Masuda T . (2003). Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells. Am J Pathol 163: 1911–1919.
  Article CAS PubMed PubMed Central Google Scholar
• Bender TP, Kremer CS, Kraus M, Buch T, Rajewsky K . (2004). Critical functions for c-Myb at three checkpoints during thymocyte development. Nat Immunol 5: 721–729.
  Article CAS PubMed Google Scholar
• Black AR, Jensen D, Lin SY, Azizkhan JC . (1999). Growth cell cycle regulation of Sp1 phosphorylation. J Biol Chem 274: 1207–1215.
  Article CAS PubMed Google Scholar
• Bright RK, Vocke CD, Emmert-Buck MR, Duray PH, Solomon D, Fetsch P et al. (1997). Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res 57: 995–1002.
  CAS PubMed Google Scholar
• Brothman AR, Swanson G, Maxwell TM, Cui J, Murphy KJ, Herrick J et al. (2005). Global hypomethylation is common in prostate cancer cells: a quantitative predictor for clinical outcome? Cancer Genet Cytogenet 156: 31–36.
  Article CAS PubMed Google Scholar
• Cho M, Uemura H, Kim SC, Kawada Y, Yoshida K, Hirao Y et al. (2001). Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma. Br J Cancer 85: 563–567.
  Article CAS PubMed PubMed Central Google Scholar
• Esteller M, Corn PG, Baylin SB, Herman JG . (2001). A gene hypermethylation profile of human cancer. Cancer Res 61: 3225–3229.
  CAS PubMed Google Scholar
• Frampton J, Ramqvist T, Graf T . (1996). v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells. Genes Dev 10: 2720–2721.
  Article CAS PubMed Google Scholar
• Gaubatz S, Imhof A, Dosch R, Werner O, Mitchell P, Buettner R et al. (1995). Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J 14: 1508–1519.
  Article CAS PubMed PubMed Central Google Scholar
• Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW et al. (2003). Induction of tumors in mice by genomic hypomethylation. Science 300: 489–492.
  Article CAS PubMed Google Scholar
• Gibadulinova A, Barathova M, Kopacek J, Hulikova A, Pastorekova S, Kettmann R et al. (2005). Expression of S100P protein correlates with and contributes to the tumorigenic capacity of HeLa cervical carcinoma cells. Oncol Rep 14: 575–582.
  CAS PubMed Google Scholar
• Gupta A, Godwin AK, Vanderveer L, Lu A, Liu J . (2003). Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Cancer Res 63: 664–673.
  CAS PubMed Google Scholar
• Herman J, Graff J, Myohanen S, Nelkin B, Baylin S . (1996). Methylation – specific PCR: a novel PCR assay for methylation status of CpG islands (DNA methylation/tumor suppressor gene/p16/p15). Proc Natl Acad Sci USA 93: 9821–9826.
  Article CAS PubMed Google Scholar
• Huang S, Jean D, Luca M, Tainsky MA, Bar-Eli M . (1998). Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis. EMBO J 17: 4358–4369.
  Article CAS PubMed PubMed Central Google Scholar
• Iozzo RV, Eichstetter I, Danielson KG . (1995). Aberrant expression of the growth factor Wnt-5A in human malignancy. Cancer Res 55: 3495–3499.
  CAS PubMed Google Scholar
• Ishii Y, Kasukabe T, Honma Y . (2005). Immediate up-regulation of the calcium-binding protein S100P and its involvement in the cytokinin-induced differentiation of human myeloid leukemia cells. Biochim Biophys Acta 1745: 156–165.
  Article CAS PubMed Google Scholar
• Jemal A, Tiwari RC, Murray T, Ghafoor A Samuels A, Ward E et al. (2005). Cancer statistics, 2005. CA Cancer J Clin 55: 10–30.
  Article PubMed Google Scholar
• Jiang MS, Tang QQ, McLenithan J, Geiman D, Shillinglaw W, Henzel WJ et al. (1998). Derepression of the C/EBPalpha gene during adipogenesis: identification of AP-2alpha as a repressor. Proc Natl Acad Sci USA 95: 3467–3471.
  Article CAS PubMed PubMed Central Google Scholar
• Jones PA, Laird PW . (1999). Cancer epigenetics comes of age. Nat Genet 21: 163–167.
  Article CAS PubMed Google Scholar
• Jurata LW, Kenny DA, Gill GN . (1996). Nuclear LIM interactor, a rhombotin and LIM homeodomain interacting protein, is expressed early in neuronal development. Proc Natl Acad Sci USA 93: 11693–11698.
  Article CAS PubMed PubMed Central Google Scholar
• Klempnauer KH . (1993). Methylation-sensitive DNA binding by v-myb and c-myb proteins. Oncogene 8: 111–115.
  CAS PubMed Google Scholar
• Lang G, White JR, Argent-Katwala MJ, Allinson CG, Weston K . (2005). Myb proteins regulate the expression of diverse target genes. Oncogene 24: 1375–1384.
  Article CAS PubMed Google Scholar
• Levenson CW, Shay NF, Lee-Ambrose LM, Cousins RJ . (1993). Regulation of cysteine-rich intestinal protein by dexamethasone in the neonatal rat. Proc Natl Acad Sci USA 90: 712–715.
  Article CAS PubMed PubMed Central Google Scholar
• Li LC, Okino ST, Dahiya R . (2004). DNA methylation in prostate cancer. Biochim Biophys Acta 1704: 87–102.
  CAS PubMed Google Scholar
• Liang H, Chen Q, Coles AH, Anderson SJ, Pihan G, Bradley A et al. (2003). Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 4: 349–360.
  Article CAS PubMed Google Scholar
• Mackay A, Jones C, Dexter T, Silva RL, Bulmer K, Jones A et al. (2003). cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells. Oncogene 22: 2680–2688.
  Article CAS PubMed Google Scholar
• Matei D, Graeber TG, Baldwin RL, Karlan BY, Rao J, Chang DD . (2002). Gene expression in epithelial ovarian carcinoma. Oncogene 21: 6289–6298.
  Article CAS PubMed Google Scholar
• McPherson LA, Baichwal VR, Weigel RJ . (1997). Identification of ERF-1 as a member of the AP2 transcription factor family. Proc Natl Acad Sci USA 94: 4342–4347.
  Article CAS PubMed PubMed Central Google Scholar
• Miller JR, Hocking AM, Brown JD, Moon RT . (1999). Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene 18: 7860–7872.
  Article CAS PubMed Google Scholar
• Mousses S, Bubendorf L, Wagner U, Hostetter G, Kononen J, Cornelison R et al. (2002). Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Curr Opin Chem Biol 6: 97–101.
  Article CAS PubMed Google Scholar
• Mucenski M, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA et al. (1991). A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65: 677–689.
  Article CAS PubMed Google Scholar
• Ogishima T, Shiina H, Breault JE, Tabatabai L, Bassett WW, Enokida H et al. (2005). Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer. Clin Cancer Res 11: 1028–1036.
  CAS PubMed Google Scholar
• Ording E, Bergholtz S, Brendeford EM, Jamin N, Gabrielsen OS . (1996). Flexibility in the second half-site sequence recognised by the c-Myb R2 domain – in vitro and in vivo analysis. Oncogene 13: 1043–1051.
  CAS PubMed Google Scholar
• Oshimo Y, Nakayama H, Ito R, Kitadai Y, Yoshida K, Chayama K et al. (2003). Promoter methylation of cyclin D2 gene in gastric carcinoma. Int J Oncol 23: 1663–1670.
  CAS PubMed Google Scholar
• Pukrop T, Klemm F, Hagemann T, Gradl D, Schulz M, Siemes S et al. (2006). Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. PNAS 103: 5454–5459.
  Article CAS PubMed PubMed Central Google Scholar
• Sato N, Fukushima N, Matsubayashi H, Goggins M . (2004). Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene 23: 1531–1538.
  Article CAS PubMed Google Scholar
• Sato N, Maitra A, Fukushima N, van Heek NT, Matsubayashi H, Iacobuzio-Donahue CA et al. (2003). Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res 63: 4158–4166.
  CAS PubMed Google Scholar
• Tokizane T, Shiina H, Igawa M, Enokida H, Urakami S, Kawakami T et al. (2005). Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res 11: 5793–5801.
  Article CAS PubMed Google Scholar
• Wang D, Shin TH, Kudlow JE . (1997). Transcription factor AP-2 controls transcription of the human transforming growth factor-alpha gene. J Biol Chem 272: 14244–14250.
  Article CAS PubMed Google Scholar
• Zeng YX, Somasundaram K, Deiry WS . (1997). AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nat Genet 15: 78–82.
  Article CAS PubMed Google Scholar
• Zhu WG, Srinivasan K, Dai Z, Duan W, Druhan LJ, Ding H et al. (2003). Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter. Mol Cell Biol 23: 4056–4065.
  Article CAS PubMed PubMed Central Google Scholar